Transcriptional inhibition of manganese superoxide dismutase (SOD2) gene expression by DNA methylation of the 5' CpG island.

[1]  S. Baylin,et al.  The estrogen receptor CpG island is methylated in most hematopoietic neoplasms. , 1996, Cancer research.

[2]  J. Herman,et al.  Hypermethylation-associated inactivation indicates a tumor suppressor role for p15INK4B. , 1996, Cancer research.

[3]  D. Samid,et al.  Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial , 1995, Molecular and cellular biology.

[4]  R. Beart,et al.  Methylation of the 5' CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. , 1995, Cancer research.

[5]  F. Kaye,et al.  CDKN2 gene silencing in lung cancer by DNA hypermethylation and kinetics of p16INK4 protein induction by 5-aza 2'deoxycytidine. , 1995, Oncogene.

[6]  W. Birchmeier,et al.  Progression of carcinoma cells is associated with alterations in chromatin structure and factor binding at the E-cadherin promoter in vivo. , 1995, Oncogene.

[7]  R. Jaenisch,et al.  DNA methylation and cancer. , 1994, Human molecular genetics.

[8]  S. Baylin,et al.  Methylation of the estrogen receptor gene CpG island marks loss of estrogen receptor expression in human breast cancer cells. , 1994, Cancer research.

[9]  L. Harris,et al.  In vitro methylation of the human O6-methylguanine-DNA methyltransferase promoter reduces transcription. , 1994, Biochimica et biophysica acta.

[10]  P. Meltzer,et al.  Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Sakai,et al.  CpG methylation inactivates the promoter activity of the human retinoblastoma tumor-suppressor gene. , 1993, Oncogene.

[12]  J. Trent,et al.  Sublocalization of the gene encoding manganese superoxide dismutase (MnSOD/SOD2) to 6q25 by fluorescence in situ hybridization and somatic cell hybrid mapping. , 1992, Genomics.

[13]  J. Trent,et al.  Loss of heterozygosity for loci on the long arm of chromosome 6 in human malignant melanoma. , 1991, Cancer research.

[14]  C. Duckett,et al.  DNA CpG methylation inhibits binding of NF-kappa B proteins to the HIV-1 long terminal repeat cognate DNA motifs. , 1991, The New biologist.

[15]  Y. Ho,et al.  Molecular structure of a functional rat gene for manganese-containing superoxide dismutase. , 1991, American journal of respiratory cell and molecular biology.

[16]  M. Comb,et al.  CpG methylation inhibits proenkephalin gene expression and binding of the transcription factor AP-2 , 1990, Nucleic Acids Res..

[17]  L. Oberley,et al.  Free radicals cancer and aging , 1986 .

[18]  B. Halliwell,et al.  Free radicals in biology and medicine , 1985 .

[19]  R. Roeder,et al.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. , 1983, Nucleic acids research.

[20]  L. Oberley,et al.  Role of superoxide dismutase in cancer: a review. , 1979, Cancer research.

[21]  Roy L. Walford,et al.  Free radicals, aging, and degenerative diseases , 1986 .